Akari Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
29 Dec 23 | Buy€904,701 | Raymond Prudo-Chlebosz | Individual | 473,934 | €1.91 | |
06 Oct 23 | Buy€406,565 | Raymond Prudo-Chlebosz | Individual | 130,303 | €3.12 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 419,745 | 5.3% |
Institutions | 866,473 | 10.9% |
Individual Insiders | 2,610,583 | 32.9% |
General Public | 4,026,894 | 50.8% |
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 56.7%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
1,307,202 | €1.8m | 394% | no data | |||
1,165,790 | €1.6m | 68.5% | no data | |||
553,804 | €756.2k | 0% | no data | |||
400,383 | €546.7k | 0% | no data | |||
164,026 | €224.0k | -7.9% | 1.22% | |||
87,628 | €119.7k | 0% | 0.05% | |||
77,590 | €105.9k | 61% | no data | |||
23,643 | €32.3k | 0% | no data | |||
19,355 | €26.4k | 0% | no data | |||
19,354 | €26.4k | 0% | 100.0% | |||
10,269 | €14.0k | -41.2% | no data | |||
10,000 | €13.7k | 0% | no data | |||
10,000 | €13.7k | 0% | no data | |||
10,000 | €13.7k | 0% | no data | |||
10,000 | €13.7k | 0% | no data | |||
10,000 | €13.7k | 0% | no data | |||
10,000 | €13.7k | -5.53% | no data | |||
6,114 | €8.3k | 0% | no data | |||
1,422 | €1.9k | -7.72% | no data | |||
150 | €204.5 | 0% | no data | |||
50 | €68.2 | 0% | no data | |||
8 | €10.8 | 0% | no data | |||
7 | €9.7 | 0% | no data | |||
5 | €6.5 | 0% | no data | |||
1 | €1.1 | 0% | no data |